Bridging Glycemic and Lipid Control: Effects of Dapagliflozin in Co-Morbid Diabetes and Heart Failure – A Randomized Controlled Trial
Authors
- Sarumathy Sundararajan
- Laxmi Sankalpa Bhaganagarapu
- Vengatesh Munusamy
Institutions
- SRM Institute of Science and Technology (IN)
Publication Details
- Journal
- Endocrine Metabolic & Immune Disorders - Drug Targets
- Published
- 2026-01-15
- DOI
- https://doi.org/10.2174/0118715303398749251027044323
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00